Editorial on Special Issue “Quantitative PET and SPECT”

by Floris H. P. van Velden, Lioe-Fee de Geus-Oei
Published 2022-08-01

PET/CT in Patients with Breast Cancer Treated with Immunotherapy

by Sofia C. Vaz, Stephanie L. Graff, Arlindo R. Ferreira, Márcio Debiasi, Lioe-Fee de Geus-Oei
Published 2023-05-01

Ablation margin quantification after thermal ablation of malignant liver tumors: How to optimize the procedure? A systematic review of the available evidence

by Pim Hendriks, Fleur Boel, Timo TM Oosterveer, Alexander Broersen, Lioe-Fee de Geus-Oei, Jouke Dijkstra, Mark C Burgmans
Published 2023-12-01

Molecular Targeted Positron Emission Tomography Imaging and Radionuclide Therapy of Pancreatic Ductal Adenocarcinoma

by Thomas T. Poels, Floris A. Vuijk, Lioe-Fee de Geus-Oei, Alexander L. Vahrmeijer, Daniela E. Oprea-Lager, Rutger-Jan Swijnenburg
Published 2021-12-01

Striatal dopamine synthesis capacity in autism spectrum disorder and its relation with social defeat: an [18F]-FDOPA PET/CT study

by Rik Schalbroeck, Floris H. P. van Velden, Lioe-Fee de Geus-Oei, Maqsood Yaqub, Therese van Amelsvoort, Jan Booij, Jean-Paul Selten
Published 2021-01-01

Nanocarriers as a Tool for the Treatment of Colorectal Cancer

by Ana Luiza C. de S. L. Oliveira, Timo Schomann, Lioe-Fee de Geus-Oei, Ellen Kapiteijn, Luis J. Cruz, Raimundo Fernandes de Araújo Junior
Published 2021-08-01

Adding the temporal domain to PET radiomic features.

by Wyanne A Noortman, Dennis Vriens, Cornelis H Slump, Johan Bussink, Tineke W H Meijer, Lioe-Fee de Geus-Oei, Floris H P van Velden
Published 2020-01-01

Cerebral [¹⁸F]-FDOPA Uptake in Autism Spectrum Disorder and Its Association with Autistic Traits

by Rik Schalbroeck, Lioe-Fee de Geus-Oei, Jean-Paul Selten, Maqsood Yaqub, Anouk Schrantee, Therese van Amelsvoort, Jan Booij, Floris H. P. van Velden
Published 2021-12-01

Radioiodine in Differentiated Thyroid Carcinoma: Do We Need Diagnostic Pre-Ablation Iodine-123 Scintigraphy to Optimize Treatment?

by Elizabeth J. de Koster, Taban Sulaiman, Jaap F. Hamming, Abbey Schepers, Marieke Snel, Floris H. P. van Velden, Lioe-Fee de Geus-Oei, Dennis Vriens
Published 2021-03-01

Stereotactic radiotherapy boost after definite chemoradiation for non-responding locally advanced NSCLC based on early response monitoring 18F-FDG-PET/CT

by Tineke W.H. Meijer, Robin Wijsman, Edwin A. Usmanij, Olga C.J. Schuurbiers, Peter van Kollenburg, Liza Bouwmans, Johan Bussink, Lioe-Fee de Geus-Oei
Published 2018-07-01

Optimal respiratory-gated [18F]FDG PET/CT significantly impacts the quantification of metabolic parameters and their correlation with overall survival in patients with pancreatic d...

by Esther M. M. Smeets, Dominique S. Withaar, Willem Grootjans, John J. Hermans, Kees van Laarhoven, Lioe-Fee de Geus-Oei, Martin Gotthardt, Erik H. J. G. Aarntzen
Published 2019-03-01

18F-fluorodeoxyglucose positron-emission tomography (FDG-PET)-Radiomics of metastatic lymph nodes and primary tumor in non-small cell lung cancer (NSCLC) - A prospective externally...

by Sara Carvalho, Ralph T H Leijenaar, Esther G C Troost, Janna E van Timmeren, Cary Oberije, Wouter van Elmpt, Lioe-Fee de Geus-Oei, Johan Bussink, Philippe Lambin
Published 2018-01-01

Impact of the COVID‐19 pandemic on the in‐hospital diagnostic pathway of breast and colorectal cancer in the Netherlands: A population‐based study

by Wouter Wolfkamp, Joyce Meijer, Jolanda C. vanHoeve, Felice vanErning, Lioe‐Fee deGeus‐Oei, Ignace deHingh, Jeroen Veltman, Sabine Siesling, the COVID and Cancer‐NL Consortium
Published 2024-01-01

Can transplant renal scintigraphy predict the duration of delayed graft function? A dual center retrospective study.

by Stan Benjamens, Robert A Pol, Lioe-Fee de Geus-Oei, Aiko P J de Vries, Andor W J M Glaudemans, Stefan P Berger, Riemer H J A Slart
Published 2018-01-01

Experimental validation of absolute SPECT/CT quantification for response monitoring in patients with coronary artery disease

by Alina van de Burgt, Petra Dibbets-Schneider, Cornelis H. Slump, Arthur J. H. A. Scholte, Douwe E. Atsma, Lioe-Fee de Geus-Oei, Floris H. P. van Velden
Published 2021-06-01

Targeting Glycans and Heavily Glycosylated Proteins for Tumor Imaging

by Ruben D. Houvast, Mireille Vankemmelbeke, Lindy G. Durrant, Manfred Wuhrer, Victor M. Baart, Peter J. K. Kuppen, Lioe-Fee de Geus-Oei, Alexander L. Vahrmeijer, Cornelis F. M. Sier
Published 2020-12-01

Effect of Oxaliplatin-Loaded Poly (<span style="font-variant: small-caps">d</span>,<span style="font-variant: small-caps">l</span>-Lactide-<i>co</i>-Glycolic Acid) (PLGA) Nanoparti...

by Ana Luiza C. de S. L. Oliveira, Raimundo Fernandes de Araújo Júnior, Thaís Gomes de Carvalho, Alan B. Chan, Timo Schomann, Filippo Tamburini, Lioe-Fee de Geus-Oei, Luis J. Cruz
Published 2020-02-01

Bone Metastases Are Measurable: The Role of Whole-Body MRI and Positron Emission Tomography

by Daniela E. Oprea-Lager, Daniela E. Oprea-Lager, Matthijs C.F. Cysouw, Ronald Boellaard, Christophe M. Deroose, Christophe M. Deroose, Christophe M. Deroose, Lioe-Fee de Geus-Oei, Lioe-Fee de Geus-Oei, Egesta Lopci, Luc Bidaut, Luc Bidaut, Ken Herrmann, Laure S. Fournier, Laure S. Fournier, Laure S. Fournier, Tobias Bäuerle, Nandita M. deSouza, Nandita M. deSouza, Nandita M. deSouza, Frederic E. Lecouvet, Frederic E. Lecouvet
Published 2021-11-01

Health-related quality of life following FDG-PET/CT for cytological indeterminate thyroid nodules

by Elizabeth J de Koster, Olga Husson, Eveline W C M van Dam, G Sophie Mijnhout, Romana T Netea-Maier, Wim J G Oyen, Marieke Snel, Lioe-Fee de Geus-Oei, Dennis Vriens
Published 2022-07-01

Reinducing Radioiodine-Sensitivity in Radioiodine-Refractory Thyroid Cancer Using Lenvatinib (RESET): Study Protocol for a Single-Center, Open Label Phase II Trial

by Maaike Dotinga, Dennis Vriens, Floris H. P. van Velden, Mette K. Stam, Jan W. T. Heemskerk, Petra Dibbets-Schneider, Martin Pool, Daphne D. D. Rietbergen, Lioe-Fee de Geus-Oei, Ellen Kapiteijn
Published 2022-12-01